We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

144 hedge funds and large institutions have $1.29B invested in IVERIC bio, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 18

31% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 45

4% more funds holding

Funds holding: 139144 (+5)

18% less capital invested

Capital invested by funds: $1.58B → $1.29B (-$292M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

32% less call options, than puts

Call options by funds: $4.47M | Put options by funds: $6.56M

Holders
144
Holders Change
+5
Holders Change %
+3.6%
% of All Funds
4.02%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
24
Increased
59
Reduced
45
Closed
18
Calls
$4.47M
Puts
$6.56M
Net Calls
-$2.09M
Net Calls Change
-$369K
Name Holding Trade Value Shares
Change
Change in
Stake
TD Asset Management
51
TD Asset Management
Ontario, Canada
$1.67M +$53K +1,000 +2%
GC
52
Guggenheim Capital
Illinois
$1.67M +$2.18M +41,197 New
Wells Fargo
53
Wells Fargo
California
$1.64M +$141K +2,664 +7%
US Bancorp
54
US Bancorp
Minnesota
$1.55M +$1.06M +20,000 +110%
Jacobs Levy Equity Management
55
Jacobs Levy Equity Management
New Jersey
$1.52M +$897K +16,930 +82%
NFA
56
Nationwide Fund Advisors
Ohio
$1.46M +$457K +8,628 +32%
BBA
57
Baker Bros. Advisors
New York
$1.44M
TA
58
Teachers Advisors
New York
$1.4M
TAM
59
Tocqueville Asset Management
New York
$1.33M +$577K +10,900 +49%
Millennium Management
60
Millennium Management
New York
$1.32M +$64K +1,209 +4%
Swiss National Bank
61
Swiss National Bank
Switzerland
$1.24M +$233K +4,400 +17%
ProShare Advisors
62
ProShare Advisors
Maryland
$1.17M -$86.6K -1,634 -5%
SEI Investments
63
SEI Investments
Pennsylvania
$1.14M +$1.47M +27,817 +10,617%
Deutsche Bank
64
Deutsche Bank
Germany
$1.06M -$2.81M -53,134 -67%
AQR Capital Management
65
AQR Capital Management
Connecticut
$978K -$225K -4,250 -15%
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$961K
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$912K +$83.4K +1,574 +8%
AIG
68
American International Group
New York
$876K +$384K +7,249 +50%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$868K +$28.7K +541 +3%
BA
70
BlackRock Advisors
Delaware
$861K -$2.34M -44,165 -68%
CAN
71
Cetera Advisor Networks
California
$858K +$1.12M +21,186 New
RJA
72
Raymond James & Associates
Florida
$817K -$24.6K -464 -2%
Citigroup
73
Citigroup
New York
$816K +$465K +8,781 +77%
TI
74
Trexquant Investment
Connecticut
$806K +$1.05M +19,900 New
GC
75
Globeflex Capital
California
$805K -$90.1K -1,700 -8%

ISEE Hedge Fund Activity: Q3 2015 in Review

144 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2015, worth a combined $1.29B — down 18% from $1.58B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ISEE positions and 18 closed out — a net gain of 6 holders — while 59 added to existing stakes and 45 trimmed.

The largest buyer was Vanguard Group, adding an estimated $19.4M. The largest seller was Fidelity Investments, cutting an estimated $17.2M.

  • 144 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2015, up from 139 in Q2 2015.
  • Funds reported $1.29B of IVERIC bio, Inc. Common Stock stock for Q3 2015, down 18% quarter-over-quarter.
  • 24 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2015 and 18 closed out, a net change of +6 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q3 2015 was Vanguard Group, an estimated $19.4M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q3 2015 was Fidelity Investments, an estimated $17.2M sold.

Based on aggregated 13F filings for Q3 2015.